Gracilin-Derivatives as Lead Compounds for Anti-inflammatory Effects.


Journal

Cellular and molecular neurobiology
ISSN: 1573-6830
Titre abrégé: Cell Mol Neurobiol
Pays: United States
ID NLM: 8200709

Informations de publication

Date de publication:
May 2020
Historique:
received: 30 07 2019
accepted: 05 11 2019
pubmed: 16 11 2019
medline: 29 12 2020
entrez: 16 11 2019
Statut: ppublish

Résumé

Gracilins are diterpenes derivative, isolated from the marine sponge Spongionella gracilis. Natural gracilins and synthetic derivatives have shown antioxidant, immunosuppressive, and neuroprotective capacities related to the affinity for cyclophilins. The aim of this work was to study anti-inflammatory and immunosuppressive pathways modulated by gracilin L and two synthetic analogues, compound 1 and 2, on a cellular model of inflammation. In this way, the murine BV2 microglia cell line was used. To carry out the experiments, microglia cells were pre-treated with compounds for 1 h and then stimulated with lipopolysaccharide for 24 h to determine reactive oxygen species production, mitochondrial membrane potential, the release of nitric oxide, interleukin-6 and tumor necrosis factor-α and the expression of Nuclear factor-erythroid 2-related factor 2, Nuclear Factor-κB, the inducible nitric oxide synthase, and the cyclophilin A. Finally, a co-culture of neuron SH-SY5Y and microglia BV2 cells was used to check the neuroprotective effect of these compounds. Cyclosporine A was used as a control of effect. The compounds were able to decrease inflammatory mediators, the expression of inflammatory target proteins as well as they activated anti-oxidative mechanism upon inflammatory conditions. For this reason, natural and synthetic gracilins could be interesting for developing anti-inflammatory drugs.

Identifiants

pubmed: 31729596
doi: 10.1007/s10571-019-00758-5
pii: 10.1007/s10571-019-00758-5
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Diterpenes 0
Interleukin-6 0
Lipopolysaccharides 0
NF-E2-Related Factor 2 0
NF-kappa B 0
Reactive Oxygen Species 0
Tumor Necrosis Factor-alpha 0
gracilin L 0
Nitric Oxide 31C4KY9ESH
Cyclosporine 83HN0GTJ6D
Nitric Oxide Synthase Type II EC 1.14.13.39

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

603-615

Subventions

Organisme : Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia
ID : 2017 GRC GI-1682
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : AGL2016-78728-R
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : ISCIII/PI16/01830
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : RTC-2016-5507-2
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : ITC-20161072
Organisme : European Commission
ID : 0161-Nanoeaters -1-E-1
Organisme : European Commission
ID : Interreg AlertoxNet EAPA-317-2016
Organisme : European Commission
ID : Interreg Agritox EAPA-998-2018
Organisme : Horizon 2020
ID : 778069-EMERTOX

Références

Cell Death Dis. 2013 Oct 31;4:e888
pubmed: 24176846
Mol Pharm. 2019 Apr 1;16(4):1456-1466
pubmed: 30821469
CNS Neurosci Ther. 2017 Jan;23(1):33-44
pubmed: 27421686
Biomed Res Int. 2013;2013:484613
pubmed: 24455696
J Nat Prod. 2009 Aug;72(8):1471-6
pubmed: 19601607
Inflamm Allergy Drug Targets. 2011 Dec;10(6):455-63
pubmed: 21999179
Front Biosci (Landmark Ed). 2011 Jan 01;16:1733-45
pubmed: 21196259
Cell Immunol. 2009;260(1):6-13
pubmed: 19733345
Dev Neurosci. 2015;37(4-5):363-75
pubmed: 25721106
Genes Dev. 2003 Sep 15;17(18):2205-32
pubmed: 12975316
Int J Mol Med. 2014 Apr;33(4):1027-34
pubmed: 24535427
Int J Mol Sci. 2018 Feb 08;19(2):
pubmed: 29419744
Cytometry A. 2010 Jul;77(7):607-13
pubmed: 20583270
Annu Rev Neurosci. 1999;22:219-40
pubmed: 10202538
Biochem Biophys Res Commun. 2017 Oct 14;492(2):172-177
pubmed: 28830815
J Physiol Pharmacol. 2003 Dec;54(4):469-87
pubmed: 14726604
Front Immunol. 2016 Oct 24;7:452
pubmed: 27822214
Methods Mol Med. 2005;110:69-78
pubmed: 15901928
Nat Chem. 2019 Apr;11(4):342-350
pubmed: 30903037
Curr Biol. 2014 May 19;24(10):R453-62
pubmed: 24845678
Biochim Biophys Acta. 2014 Dec;1840(12):3311-9
pubmed: 25152356
Plant Signal Behav. 2013 Jan;8(1):e22734
pubmed: 23123451
Mar Drugs. 2014 Jan 27;12(2):700-18
pubmed: 24473170
Neuropharmacology. 2015 Jun;93:285-93
pubmed: 25724081
Nature. 1995 Apr 13;374(6523):647-50
pubmed: 7715705
Drug Metab Pharmacokinet. 2008;23(3):150-7
pubmed: 18574318
Mar Drugs. 2010 Apr 22;8(4):1417-68
pubmed: 20479984
Clin Implant Dent Relat Res. 2018 Apr;20(2):102-109
pubmed: 29057571
Drug Discov Today. 2003 Jun 15;8(12):536-44
pubmed: 12821301
Neurosci Res. 2011 Jun;70(2):220-9
pubmed: 21291924
Cell Physiol Biochem. 2015;37(2):779-92
pubmed: 26356268
Antonie Van Leeuwenhoek. 2000 Feb;77(2):135-45
pubmed: 10768472
Brain Res. 2011 Jun 13;1395:12-20
pubmed: 21555117
Cell Mol Life Sci. 2017 Aug;74(15):2795-2813
pubmed: 28378042
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7531-6
pubmed: 9207126
Pharmacol Res. 2016 May;107:407-414
pubmed: 27041481
Biophys J. 2015 Apr 7;108(7):1739-1746
pubmed: 25863065
PLoS One. 2015 Feb 19;10(2):e0118372
pubmed: 25695433
Eur J Pharmacol. 2007 Jun 14;564(1-3):47-56
pubmed: 17362920
Metab Brain Dis. 2015 Apr;30(2):393-400
pubmed: 24733573
J Leukoc Biol. 2017 Oct;102(4):989-992
pubmed: 28729360
PLoS One. 2011 Apr 29;6(4):e18285
pubmed: 21559518
Cell. 1994 Sep 23;78(6):919-25
pubmed: 7923361
Neuroscience. 2007 Jul 29;147(4):867-83
pubmed: 17459594

Auteurs

Sandra Gegunde (S)

Pharmacology Department, Facultad de Veterinaria, Universidad de Santiago de Compostela, 27002, Lugo, Spain.

Amparo Alfonso (A)

Pharmacology Department, Facultad de Veterinaria, Universidad de Santiago de Compostela, 27002, Lugo, Spain. amparo.alfonso@usc.es.

Eva Alonso (E)

Pharmacology Department, Facultad de Veterinaria, Universidad de Santiago de Compostela, 27002, Lugo, Spain.
Fundación Instituto de Investigación Sanitaria Santiago de Compostela (FIDIS), Hospital Universitaio Lucus Augusti, 27004, Lugo, Spain.

Rebeca Alvariño (R)

Pharmacology Department, Facultad de Veterinaria, Universidad de Santiago de Compostela, 27002, Lugo, Spain.

Luis M Botana (LM)

Pharmacology Department, Facultad de Veterinaria, Universidad de Santiago de Compostela, 27002, Lugo, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH